Docetaxel plus ADT significantly improves patient outcomes
نویسندگان
چکیده
منابع مشابه
ADT ADT ADT VMM Refinement memories ADT refinement ADTs
In this paper we present our novel power exploration methodology for applications with dynamic data types. Our methodology is crucial to obtain eeective solutions in an embedded (HW or SW) processor context. The contributions are twofold. First we deene the complete search space for Virtual Memory Management (VMM) mechanisms in a struc-tured way with orthogonal decision trees. Secondly we prese...
متن کاملCapecitabine plus docetaxel combination therapy
Health technology Two treatment options for patients with anthracycline-pretreated metastatic breast carcinoma were examined. The options were capecitabine (CAP) plus docetaxel (DOC) combination therapy and DOC alone. In the former (CAP+DOC), oral capecitabine (1,250 mg/m2 twice daily was given on days 1 14, followed by a 7-day rest period, with docetaxel (75 mg/m2) administered as a 1-hour int...
متن کاملAndrogen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysis
In this paper, we reviewed the long-term survival outcomes, safety, and quality-of-life of androgen-deprivation therapy (ADT) alone versus combined with radiation therapy (RT) or chemotherapy for locally advanced and metastatic prostate cancer (PCa). A literature search was performed using OvidSP. Randomized controlled trials (RCTs) that met the following criteria were included: including local...
متن کاملPertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
BACKGROUND The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive metastatic breast cancer. However, most cases of advanced disease eventually progress. Pertuzumab, an anti-HER2 humanized monoclonal antibody that inhibits receptor dimerization, has a mechanism of action that is complementary to that ...
متن کاملDocetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
PURPOSE Androgen ablation is the standard initial treatment for advanced prostate cancer; however, tumors eventually develop androgen independence and become incurable. Chemotherapy is commonly used after hormone treatment fails but has not shown significant survival benefit. Studies suggest that androgen ablation can select for a population of hormone-independent cells that are also relatively...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2015
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2015.145